Stockreport

Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens [Yahoo! Finance]

Acurx Pharmaceuticals, Inc.  (ACXP) 
PDF enzyme of Gram-positive bacteria including C. difficile , MRSA, VRE and PRSP (penicillin-resistant Streptococcus pneumonia) Acurx's lead DNA pol IIIC antibiotic, ibeza [Read more]